CAMBRIDGE, Mass., July 25, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will report its financial results for the second quarter ending June 30, 2011 before the U.S. financial markets open on Thursday, August 4, 2011.
